Segluromet
Product Images NDC 50090-6217

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Segluromet (NDC 50090-6217). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500906217)

FDA Label Image

Chemical Structure (Segluromet 01)

FDA Label Image

Chemical Structure (Segluromet 02)

FDA Label Image

Figure 1 (Segluromet 03)

Figure 1 (Segluromet 03)
This is a list of different medications and their doses, including Sitagliptin, Metiormin, Glimepiride, Simvastatin, and Ritampin. The list also includes results from various tests such as Auc and Cmax, as well as a geometric mean ratio. The text does not provide a clear context for these medications, their purpose, or the reason for the tests.*
FDA Label Image

Figure 2 (Segluromet 04)

Figure 2 (Segluromet 04)
This appears to be a table of medications with their dosages and some numerical values indicating the concentration of the medication in the patients' blood. The drugs listed include Sitagliptin, Metformin, Glimepiride, and Simvastatin. There are also values for the geometric mean ratio and some percentages. It's unclear what the context or purpose of this table is, but it is likely related to tracking the efficacy or side effects of these medications in patients.*
FDA Label Image

Figure 3 (Segluromet 05)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.